Observational studyJournal of nursing management2026
Personalized Nursing Approaches in Monitoring and Managing Hematoma Risks After Percutaneous Renal Biopsy: A Prospective Observational Study.
Observational study in Journal of nursing management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Personalized Nursing Approaches in Monitoring and Managing Hematoma Risks After Percutaneous Renal Biopsy: A Prospective Observational Study.Journal of nursing management · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates factors associated with large hematomas after percutaneous renal biopsy (PRB) and describes PRB-related complications in patients with native kidneys.
methodsA prospective observational cohort study was conducted from September 2023 to May 2024 on 418 patients undergoing PRB at a nephrology department. The study collected data including demographic details, laboratory data, and preprocedure renal ultrasonography findings. The advanced practice nurse utilized point-of-care ultrasound to conduct immediate bedside ultrasound examinations following PRB. Postoperative monitoring involved periodic ultrasound assessments to measure hematoma size at 1, 6, and 24 h after the biopsy, complemented by pain evaluations using the Visual Analog Scale at 6 and 24 h.
resultsThe study investigated complications in 418 patients post-PRB, revealing that 7.7% experienced hematuria and hematoma incidence increased from 45.5% at 1 h to 56.0% at 24 h. ROC curve analysis identified critical cutoffs for predicting significant hematoma growth: 3.05 cm at 1 h (AUC = 0.827) and 4.125 cm at 6 h (AUC = 0.899). Factors significantly linked to larger hematomas at 24 h included activated partial thromboplastin time (APTT) (OR = 1.25, p = 0.001), 6-h hematoma diameter (OR = 2.05, p < 0.001), and 24-h post-PRB pain score at the puncture site (OR = 1.28, p = 0.022).
conclusionHigher APTT, larger hematoma diameter at 6 h, and higher puncture-site pain scores at 24 h were associated with large hematomas (≥ 5 cm) after PRB. These factors may serve as markers to support risk-stratified postbiopsy monitoring. Further studies are needed to determine whether nursing interventions guided by these markers can reduce complications or improve patient outcomes. IMPLICATIONS FOR NURSING MANAGEMENT: Nurse-led post-PRB monitoring may incorporate APTT, 6-h hematoma diameter, and pain assessment to support risk-informed surveillance. In clinically stable patients without signs of hematoma progression, light ambulation may be considered as an alternative to prolonged strict bed rest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.